US Department of Justice Files Motion to Dismiss Pro-Marijuana Lawsuit, Makes Note of Rescheduling Effort

The United States Department of Justice (DOJ) has officially filed a motion to dismiss a lawsuit challenging the government’s prohibition on marijuana.

Yesterday we reported that the DOJ filed documents with the U.S. District Court for the District of Massachusetts declaring that it will be seeking to dismiss the lawsuit prior to the court-appointed deadline of January 23. Today, the day of the deadline, the DOJ officially filed the motion to dismiss. The motion was filed by Brian M. Boynton, Principal Deputy Assistant Attorney General, Brigham J. Bowen, Assistant Director, Federal Programs Branch, and Jeremy S.B. Newman, a DOJ Trial Attorney, on behalf of Attorney General Merrick Garland.

“Defendant Merrick Garland, in his official capacity as Attorney General of the United States, hereby files this Motion to Dismiss Complaint”, states the filing. :As set forth in the accompanying Memorandum, the Complaint, ECF No. 1, filed by Plaintiffs Canna Provisions, Inc., Gyasi Sellers, Wiseacre Farm, Inc., and Verano Holdings Corp. (collectively, “Plaintiffs”), should be dismissed because Plaintiffs lack standing and because Plaintiffs fail to state a claim upon which relief can be granted. Accordingly, the Court should grant this Motion and dismiss the Complaint.”

In the filing, the DOJ points out that the Drug Enforcement Administration (DEA) is currently considering a request from the Department of Health and Human Services to reschedule marijuana.

“It is not for the courts to disrupt or get ahead of that administrative process,” says Garland, who points out that federal lawmakers have “set up an administrative process for rescheduling” marijuana.

The DOJ argues that the marijuana companies who filed the lawsuit didn’t have legal standing to do so, namely because they have not faced federal persecution or prosecution for operating state-legal marijuana businesses.

In the filing the DOJ says federal regulation of intrastate marijuana activities is constitutional because such activities “substantially affect interstate commerce”.  They say “Plaintiffs get no further by claiming that the CSA [Controlled Substances Act] violates their right to substantive due process. Courts have consistently, and correctly, held that no fundamental right exists to distribute, possess, or use marijuana. Therefore, the CSA is subject only to deferential rational basis review, which it easily survives.”

The DOJ concludes by simply stating “For the forgoing reasons, the Court should dismiss the Complaint.”

The lawsuit in question claims that continuing marijuana prohibition, in particular enforcing federal marijuana policy on states that have legalized the plant, is unconstitutional and harms public safety.

“What was once a single-minded federal crusade against the cannabis plant has been replaced with an ambivalent set of inconsistent policies, some aimed at reducing federal interference with state efforts to regulate marijuana,” says the lawsuit. “In short, the federal government has long ago abandoned the goal of eliminating marijuana from commerce. Nor does Congress have any comprehensive—or even consistent and rational—approach to marijuana regulation. This inconsistent, patchwork approach to marijuana regulation provides no basis for Congress to regulate intrastate marijuana.”

The lawsuit states that “prohibition is to the detriment of the states, their citizens, and Plaintiffs. Not only do Plaintiffs face the potential risk of enforcement, their businesses also face numerous hurdles that result directly from the CSA’s treatment of intrastate marijuana.”

Congressional Researchers say it’s “likely” marijuana will be moves to Schedule III, legalizing it nationwide for prescription use, by the end of 2024.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can signup for our newsletter by clicking here

 

 

More articles from The Marijuana Herald.

Florida Lawmaker Files Bill to Ban Public Marijuana Smoking Across the State

Florida Lawmaker Files Bill to Ban Public Marijuana Smoking Across the State

Massachusetts Cannabis Regulators Expected to Finalize Long-Delayed Social Consumption Rules by Christmas

Massachusetts Cannabis Regulators Expected to Finalize Long-Delayed Social Consumption Rules by Christmas

Curaleaf Appeals $31.8 Million Judgment in Michigan Contract Fight With Hello Farms

Curaleaf Appeals $31.8 Million Judgment in Michigan Contract Fight With Hello Farms

Arizona Marijuana Tax Revenue Reached $20.7 Million in October, $233.2 Million Year-to-Date in 2025

Arizona Marijuana Tax Revenue Reached $20.7 Million in October, $233.2 Million Year-to-Date in 2025

New Jersey Bill Would Expand Dispensary Access, Loosen CRC Restrictions, and Strengthen Enforcement Against Illegal Operators

New Jersey Bill Would Expand Dispensary Access, Loosen CRC Restrictions, and Strengthen Enforcement Against Illegal Operators

THC Strengthens Brain-Based Pain Filtering in Fibromyalgia, New Clinical Trial Finds

THC Strengthens Brain-Based Pain Filtering in Fibromyalgia, New Clinical Trial Finds

Hemp Shows Strong Antiviral Activity Against Japanese Encephalitis Virus

Hemp Shows Strong Antiviral Activity Against Japanese Encephalitis Virus

Higher Light Intensity During Flowering Found to Boost CBD Production in Hemp

Higher Light Intensity During Flowering Found to Boost CBD Production in Hemp

Psilocybin Shows Potential to Improve Long-Term Effects of Repetitive Brain Injuries Linked to Intimate Partner Violence

Psilocybin Shows Potential to Improve Long-Term Effects of Repetitive Brain Injuries Linked to Intimate Partner Violence

Florida Campaign to Legalize Recreational Cannabis Has Submitted 675,000 Verified Signatures for 2026 Initiative

Florida Campaign to Legalize Recreational Cannabis Has Submitted 675,000 Verified Signatures for 2026 Initiative

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells